DR

Devendra Rao Mandapati

Active Director Director DIN 10092557
DIN 10092557 First appointment Jul 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Devendra Rao Mandapati

Data last updated:

Devendra Rao Mandapati is a Director at Orginpulse Pharmaceuticals Private Limited (since 2024). The company operates in Pharma.

DIN 10092557
Primary Designation Director
Industry Pharma
First Appointment 06 Jul 2024
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director06 Jul 20242021Active

Board colleagues of Devendra Rao Mandapati

Directorship timeline

Open interactive timeline →
Orginpulse Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Devendra Rao Mandapati

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Devendra Rao Mandapati

Devendra Rao Mandapati currently holds 1 directorship: Orginpulse Pharmaceuticals Private Limited (Director, since 06 Jul 2024).

Devendra Rao Mandapati was first appointed on 06 Jul 2024 as Director at Orginpulse Pharmaceuticals Private Limited.

The current boards of Devendra Rao Mandapati's companies include Galibsaheb Valluri (Orginpulse Pharmaceuticals Private Limited), Kosuri Rama Sai Samhit Varma (Orginpulse Pharmaceuticals Private Limited), Ranjithreddy Namireddy (Orginpulse Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available